|
|
|
|
| LEADER |
01531nam a2200265 u 4500 |
| 001 |
EB002010687 |
| 003 |
EBX01000000000000001173586 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
220201 r ||| eng |
| 100 |
1 |
|
|a Crain, Janet
|
| 245 |
0 |
0 |
|a Current practice analysis
|h Elektronische Ressource
|b interventions for insomnia disorder
|c Janet Crain, Michael Raj, Sarah Garland, Sarah Jones, Bechara Farah
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa
|b Canadian Agency for Drugs and Technologies in Health
|c 2017, June 2017
|
| 300 |
|
|
|a 1 PDF file (34 pages)
|b illustrations
|
| 700 |
1 |
|
|a Raj, Michael
|e [author]
|
| 700 |
1 |
|
|a Garland, Sarah
|e [author]
|
| 700 |
1 |
|
|a Jones, Sarah
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH technology review
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK487377
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a CADTH studied the use of interventions to treat insomnia disorder (acute and chronic) in Canadian primary care practice. The study investigated current practices and trends in drug and non-drug therapies for patients with insomnia disorder from the perspective of family physicians, nurse practitioners, and pharmacists. The findings are based on a targeted literature review as well as on the results of qualitative research from surveys of primary care practitioners. This report presents a summary of findings
|